Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2021

Open Access 01-12-2021 | Tuberculosis | Research

Determinant factors for loss to follow-up in drug-resistant tuberculosis patients: the importance of psycho-social and economic aspects

Authors: Soedarsono Soedarsono, Ni Made Mertaniasih, Tutik Kusmiati, Ariani Permatasari, Ni Njoman Juliasih, Cholichul Hadi, Ilham Nur Alfian

Published in: BMC Pulmonary Medicine | Issue 1/2021

Login to get access

Abstract

Background

Drug-resistant tuberculosis (DR-TB) is the barrier for global TB elimination efforts with a lower treatment success rate. Loss to follow-up (LTFU) in DR-TB is a serious problem, causes mortality and morbidity for patients, and leads to wide spreading of DR-TB to their family and the wider community, as well as wasting health resources. Prevention and management of LTFU is crucial to reduce mortality, prevent further spread of DR-TB, and inhibit the development and transmission of more extensively drug-resistant strains of bacteria. A study about the factors associated with loss to follow-up is needed to develop appropriate strategies to prevent DR-TB patients become loss to follow-up. This study was conducted to identify the factors correlated with loss to follow-up in DR-TB patients, using questionnaires from the point of view of patients.

Methods

An observational study with a cross-sectional design was conducted. Study subjects were all DR-TB patients who have declared as treatment success and loss to follow-up from DR-TB treatment. A structured questionnaire was used to collect information by interviewing the subjects as respondents. Obtained data were analyzed potential factors correlated with loss to follow-up in DR-TB patients.

Results

A total of 280 subjects were included in this study. Sex, working status, income, and body mass index showed a significant difference between treatment success and loss to follow-up DR-TB patients with p-value of 0.013, 0.010, 0.007, and 0.006, respectively. In regression analysis, factors correlated with increased LTFU were negative attitude towards treatment (OR = 1.2; 95% CI = 1.1–1.3), limitation of social support (OR = 1.1; 95% CI = 1.0–1.2), dissatisfaction with health service (OR = 2.1; 95% CI = 1.5–3.0)), and limitation of economic status (OR = 1.1; 95% CI = 1.0–1.2)).

Conclusions

Male patients, jobless, non-regular employee, lower income, and underweight BMI were found in higher proportion in LTFU patients. Negative attitude towards treatment, limitation of social support, dissatisfaction with health service, and limitation of economic status are factors correlated with increased LTFU in DR-TB patients. Non-compliance to treatment is complex, we suggest that the involvement and support from the combination of health ministry, labor and employment ministry, and social ministry may help to resolve the complex problems of LTFU in DR-TB patients.
Literature
1.
go back to reference World Health Organization. Global Tuberculosis Report 2020. Geneva: WHO; 2020. World Health Organization. Global Tuberculosis Report 2020. Geneva: WHO; 2020.
3.
go back to reference Heemanshu A, Satwanti K. Determinants of lost to follow up during treatment among tuberculosis patients in Delhi. Int J Med Res Health Sci. 2016;5(1):145–52. Heemanshu A, Satwanti K. Determinants of lost to follow up during treatment among tuberculosis patients in Delhi. Int J Med Res Health Sci. 2016;5(1):145–52.
4.
go back to reference World Health Organization. WHO operational handbook on tuberculosis: drug resistant tuberculosis treatment. Geneva: WHO; 2020. World Health Organization. WHO operational handbook on tuberculosis: drug resistant tuberculosis treatment. Geneva: WHO; 2020.
5.
go back to reference Soedarsono S, Kusmiati T, Wulaningrum PA, Permatasari A, Indrawanto DW. Factors cause of switching shorter regimen to longer regimen in multidrug-resistant/rifampicin-resistant tuberculosis treated patients in Dr. Soetomo Hospital Surabaya, Indonesia. Indian J Forens Med Toxicol. 2021;15(1): 1589–95. Soedarsono S, Kusmiati T, Wulaningrum PA, Permatasari A, Indrawanto DW. Factors cause of switching shorter regimen to longer regimen in multidrug-resistant/rifampicin-resistant tuberculosis treated patients in Dr. Soetomo Hospital Surabaya, Indonesia. Indian J Forens Med Toxicol. 2021;15(1): 1589–95.
6.
go back to reference Gualano G, Mencarini P, Musso M, Mosti S, Santangelo L, Murachelli S, et al. Putting in harm to cure: drug related adverse events do not affect outcome of patients receiving treatment for multidrug-resistant Tuberculosis. Experience from a tertiary hospital in Italy. PLoS ONE. 14(2): e0212948. Gualano G, Mencarini P, Musso M, Mosti S, Santangelo L, Murachelli S, et al. Putting in harm to cure: drug related adverse events do not affect outcome of patients receiving treatment for multidrug-resistant Tuberculosis. Experience from a tertiary hospital in Italy. PLoS ONE. 14(2): e0212948.
8.
go back to reference Xing W, Zhang R, Jiang W, Zhang T, Pender M, Zhou J, et al. Adherence to multidrug resistant tuberculosis treatment and case management in Chongqing, China—a mixed method research study. Infect Drug Resist. 2021;14:999–1012.CrossRef Xing W, Zhang R, Jiang W, Zhang T, Pender M, Zhou J, et al. Adherence to multidrug resistant tuberculosis treatment and case management in Chongqing, China—a mixed method research study. Infect Drug Resist. 2021;14:999–1012.CrossRef
9.
go back to reference Batte C, Namusobya MS, Kirabo R, Mukisa J, Adakun S, Katamba A. Prevalence and factors associated with non-adherence to multi-drug resistant tuberculosis (MDR-TB) treatment at Mulago National Referral Hospital, Kampala. Uganda Afri Health Sci. 2021;21(1):238–47.CrossRef Batte C, Namusobya MS, Kirabo R, Mukisa J, Adakun S, Katamba A. Prevalence and factors associated with non-adherence to multi-drug resistant tuberculosis (MDR-TB) treatment at Mulago National Referral Hospital, Kampala. Uganda Afri Health Sci. 2021;21(1):238–47.CrossRef
10.
go back to reference Mangan JM, Tupasi TE, Garfin AM, Lofranco V, Orillaza-Chi R, Basilio R, et al. Multidrug-resistant tuberculosis patients lost to follow-up: self-reported readiness to restart treatment. Int J Tuberc Lung Dis. 2016;20(9):1205–11.CrossRef Mangan JM, Tupasi TE, Garfin AM, Lofranco V, Orillaza-Chi R, Basilio R, et al. Multidrug-resistant tuberculosis patients lost to follow-up: self-reported readiness to restart treatment. Int J Tuberc Lung Dis. 2016;20(9):1205–11.CrossRef
11.
go back to reference World Health Organization. Meeting report of the WHO expert consultation on drug-resistant tuberculosis treatment outcome definitions: 17–19 November 2020. Geneva: WHO; 2021. World Health Organization. Meeting report of the WHO expert consultation on drug-resistant tuberculosis treatment outcome definitions: 17–19 November 2020. Geneva: WHO; 2021.
13.
go back to reference Hossain MM, Flora MS, Shahidullah M, Amin MN, Mosharref M, Wahab MA. Socio-demographic and economic factors associated with adherence to anti-tuberculosis treatment. JAFMC Bangladesh. 2019;15(1):39–41. Hossain MM, Flora MS, Shahidullah M, Amin MN, Mosharref M, Wahab MA. Socio-demographic and economic factors associated with adherence to anti-tuberculosis treatment. JAFMC Bangladesh. 2019;15(1):39–41.
14.
go back to reference Fang XH, Shen HH, Hu WQ, Xu QQ, Jun L, Zhang ZP, et al. Prevalence of and factors influencing anti-tuberculosis treatment non-adherence among patients with pulmonary tuberculosis: a cross-sectional study in Anhui Province. Eastern China Med Sci Monit. 2019;25:1928–35.CrossRef Fang XH, Shen HH, Hu WQ, Xu QQ, Jun L, Zhang ZP, et al. Prevalence of and factors influencing anti-tuberculosis treatment non-adherence among patients with pulmonary tuberculosis: a cross-sectional study in Anhui Province. Eastern China Med Sci Monit. 2019;25:1928–35.CrossRef
16.
go back to reference Juliasih NN, Mertaniasih NM, Hadi C, Soedarsono, Sari RM, Alfian IN. Factors affecting tuberculosis patients’ quality of life in Surabaya, Indonesia. J Multidiscip Health. 2020;13: 1475–1480. Juliasih NN, Mertaniasih NM, Hadi C, Soedarsono, Sari RM, Alfian IN. Factors affecting tuberculosis patients’ quality of life in Surabaya, Indonesia. J Multidiscip Health. 2020;13: 1475–1480.
17.
go back to reference Viana PV, Redner P, Ramos JP. Factors associated with loss to follow-up and death in cases of drug-resistant tuberculosis (DR-TB) treated at a reference center in Rio de Janeiro, Brazil. Cad. Saúde Pública 2018; 34(5):e00048217. Viana PV, Redner P, Ramos JP. Factors associated with loss to follow-up and death in cases of drug-resistant tuberculosis (DR-TB) treated at a reference center in Rio de Janeiro, Brazil. Cad. Saúde Pública 2018; 34(5):e00048217.
18.
22.
go back to reference Tupasi TE, Garfin AM, Kurbatova EV, Mangan JM, Orillaza-Chi R, Naval LC, et al. Factors associated with loss to follow-up during treatment for multidrug-resistant tuberculosis, the Philippines, 2012–2014. Emerg Infect Dis. 2016;22(3):491–502.CrossRef Tupasi TE, Garfin AM, Kurbatova EV, Mangan JM, Orillaza-Chi R, Naval LC, et al. Factors associated with loss to follow-up during treatment for multidrug-resistant tuberculosis, the Philippines, 2012–2014. Emerg Infect Dis. 2016;22(3):491–502.CrossRef
25.
go back to reference Tola HH, Tol A, Shojaeizadeh D, Garmaroudi G. Tuberculosis treatment non-adherence and lost to follow up among TB patients with or without HIV in developing countries: a systematic review. Iran J Public Health. 2015;44(1):1–11.PubMedPubMedCentral Tola HH, Tol A, Shojaeizadeh D, Garmaroudi G. Tuberculosis treatment non-adherence and lost to follow up among TB patients with or without HIV in developing countries: a systematic review. Iran J Public Health. 2015;44(1):1–11.PubMedPubMedCentral
27.
go back to reference Van Hoom R, Jaramillo E, Collins D, Gebhard A, van den Hof S. The effects of psycho-emotional and socio-economic support for tuberculosis patients on treatment adherence and treatment outcomes—a systematic review and meta-analysis. PLoS ONE 11(4): e0154095. https://doi.org/10.1371/journal.pone.0154095. Van Hoom R, Jaramillo E, Collins D, Gebhard A, van den Hof S. The effects of psycho-emotional and socio-economic support for tuberculosis patients on treatment adherence and treatment outcomes—a systematic review and meta-analysis. PLoS ONE 11(4): e0154095. https://​doi.​org/​10.​1371/​journal.​pone.​0154095.
28.
go back to reference Kendall EA, Theron D, Franke MF, Helden P, Victor TC, Murray MB. Alcohol, hospital discharge, and socioeconomic risk factors for default from multidrug resistant tuberculosis treatment in Rural South Africa: a retrospective cohort study. PLoS ONE. 2013; 8(12): e83480. Kendall EA, Theron D, Franke MF, Helden P, Victor TC, Murray MB. Alcohol, hospital discharge, and socioeconomic risk factors for default from multidrug resistant tuberculosis treatment in Rural South Africa: a retrospective cohort study. PLoS ONE. 2013; 8(12): e83480.
29.
go back to reference Kuchukhidze G, Kumar AMV, Colombani P, Khogali M, Nanava U, Blumberg HM, et al. Risk factors associated with loss to follow-up among multidrug-resistant tuberculosis patients in Georgia. Public Health Action. 2014;4(3):S41–6.CrossRef Kuchukhidze G, Kumar AMV, Colombani P, Khogali M, Nanava U, Blumberg HM, et al. Risk factors associated with loss to follow-up among multidrug-resistant tuberculosis patients in Georgia. Public Health Action. 2014;4(3):S41–6.CrossRef
Metadata
Title
Determinant factors for loss to follow-up in drug-resistant tuberculosis patients: the importance of psycho-social and economic aspects
Authors
Soedarsono Soedarsono
Ni Made Mertaniasih
Tutik Kusmiati
Ariani Permatasari
Ni Njoman Juliasih
Cholichul Hadi
Ilham Nur Alfian
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2021
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-021-01735-9

Other articles of this Issue 1/2021

BMC Pulmonary Medicine 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.